Alexey Shemyakin - Concepedia

Author

Alexey Shemyakin

Also Known As

A S Shemyakin, A Shemyakin, A. S. SHEMYAKIN, A. Shemyakin, A.S. Shemyakin, Aleksey Shemyakin, Alexey S. Shemyakin, Alexey Shemyakin

Publications

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Friedrich Schiller University Jena

About

Alexey Shemyakin is an author at Karolinska Institutet specializing in vascular biology, medicine, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	173
2	Cell Biology	2	2	91
3	Diabetes	2	2	111
4	Health Sciences	1	1	54
5	Endocrinology	1	1	54

Alexey Shemyakin

Publications

827

Citations

H-Index

Page 1

	Year	Citations
Arginase Inhibition Improves Endothelial Function in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus Alexey Shemyakin, Oskar Kövamees, Arnar Rafnsson, Circulation	2012	183
Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus Oskar Kövamees, Alexey Shemyakin, Antonio Checa, The Journal of Clinical Endocrinology & Metabolism	2016	69
Local Arginase Inhibition during Early Reperfusion Mediates Cardioprotection via Increased Nitric Oxide Production Adrian Gonon, Christian Jung, Abram Katz, PLoS ONE	2012	68
Dual Endothelin Receptor Blockade Acutely Improves Insulin Sensitivity in Obese Patients With Insulin Resistance and Coronary Artery Disease G. Ahlborg, Alexey Shemyakin, Felix Böhm, Diabetes Care	2007	61
Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes Christian Jung, Arnar Rafnsson, Alexey Shemyakin, International Journal of Cardiology Endothelial Cell PathobiologyMetabolic SyndromeEndothelial Progenitor CellsVascular DiseaseCardiovascular Disease	2009	57
Effect of Arginase Inhibition on Ischemia-Reperfusion Injury in Patients with Coronary Artery Disease with and without Diabetes Mellitus Oskar Kövamees, Alexey Shemyakin, John Pernow PLoS ONE	2014	55
Enhanced Endothelium-dependent Vasodilatation by Dual Endothelin Receptor Blockade in Individuals With Insulin Resistance Alexey Shemyakin, Felix Böhm, Henrik Wagner, Journal of Cardiovascular Pharmacology Insulin ResistanceMetabolic SyndromeCardiovascular DiseaseMedicineMicrovascular Dysfunction	2006	54
Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction Oskar Kövamees, Alexey Shemyakin, John Pernow Diabetes and Vascular Disease Research	2016	50
Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels Oskar Kövamees, Alexey Shemyakin, Mats Eriksson, Journal of Internal Medicine	2015	46
Endothelin-1 Reduces Glucose Uptake in Human Skeletal Muscle In Vivo and In Vitro Alexey Shemyakin, Firoozeh Salehzadeh, Daniella E. Duque-Guimarães, Diabetes	2011	43

Page 1